San Francisco Sentry Investment Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
San Francisco Sentry Investment Group's BIIB Position: Q2 2021 in Review
San Francisco Sentry Investment Group held its Biogen (BIIB) position steady in Q2 2021 at 83 shares worth $29K. The position accounts for 0.02% of the portfolio, ranked #434.
San Francisco Sentry Investment Group first reported a position in BIIB in Q1 2014 and has held it in 20 quarters since. The position peaked at $164K in Q3 2018. 1,104 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.
- San Francisco Sentry Investment Group held 83 shares of Biogen worth $29K as of Q2 2021.
- San Francisco Sentry Investment Group left its Biogen share count unchanged in Q2 2021.
- Biogen made up 0.02% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #434 holding.
- San Francisco Sentry Investment Group first reported a position in Biogen in Q1 2014 and has held it in 20 quarters since.
- San Francisco Sentry Investment Group's Biogen position peaked at $164K in Q3 2018.
- 1,104 funds tracked by Wall St. Rank held Biogen as of Q2 2021.
Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.